Theranostics

<div>Cell Recovery of Hydrogel-Encapsulated Cells for Molecular Analysis.-&nbsp;Bioengineered Microtissue Models of the Human Bone Metastatic Microenvironment: A Novel In Vitro Theranostics Platform for Cancer Research.-&nbsp;Real-Time and 3D Quantification of Cancer Cell Dynamics: Exploiting a Bioengineered Human Bone Metastatic Microtissue.-&nbsp;Exomes Extraction and Identification.-&nbsp;Profiling MicroRNA Markers in Plasma: Looking into Better Approaches and Recommendations.-&nbsp;Isolation and Quantification of MicroRNAs from Human Saliva.-&nbsp;The Isolation and Analysis of Circulating Tumor Cells.-&nbsp;The Isolation and Characterization of Circulating Tumor Cells from Head and Neck Cancer Patient Blood Samples using Spiral Microfluidic Technology.-&nbsp;Pharmacogenetics: Role of Genetic Variants - SNPs.-&nbsp;EGFR Mutation Analysis in Non-Small Cell Lung Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR System.- Subcellular Localization of MicroRNAs by MicroRNA In Situ Hybridization (miR-ISH).-&nbsp;Digital Holographic Imaging as a Method for Quantitative, Live Cell Imaging of Drug Response to Novel Targeted Cancer Therapies.-&nbsp;Luminescent Porous Silicon Nanoparticles for Continuous Wave and Time-Gated Photoluminescence Imaging.-&nbsp;Nucleic Acid Aptamers as Emerging Tools for Diagnostics and Theranostics.-&nbsp;Aptamer Selection for Detecting Molecular Target using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.-&nbsp;Fluorescence In Situ Hybridization and Rehybridization Using Bacterial Artificial Chromosome Probes.-&nbsp;Upconversion Nanoparticle-Base Strategy for Blood-Brain Barrier across for Central Nervous Disease Therapy.-&nbsp;Genetically Engineered Plasma Membrane Nanovesicles for Cancer-Targeted Nanotheranostics.</div>